Thrombosis Panel
GTR Test Accession: Help GTR000570017.2
NYS CLEP
CAP
CARDIOVASCULAR
Last updated in GTR: 2022-10-25
Last annual review date for the lab: 2023-06-08 Past due LinkOut
At a Glance
Diagnosis; Mutation Confirmation; Risk Assessment
Thrombotic disease
ADAMTS13 (9q34.2); F2 (11p11.2); F5 (1q24.2); FGA (4q31.3); FGB (4q31.3) more...
Molecular Genetics - Deletion/duplication analysis: Comparative Genomic Hybridization; ...
This panel is designed for the detection of germline variants …
Not provided
Not provided
Ordering Information
Offered by: Help
Versiti Diagnostic Laboratories
View lab's website
View lab's test page
Specimen Source: Help
Who can order: Help
  • Genetic Counselor
  • Health Care Provider
  • Licensed Physician
  • Nurse Practitioner
Test Order Code: Help
CPT codes: Help
**AMA CPT codes notice
Lab contact: Help
Stefanie Dugan, MS, CGC, Certified Genetic counselor, CGC, Genetic Counselor
SDugan@Versiti.org
(414) 937-6126
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order: Help
Test service: Help
Clinical Testing/Confirmation of Mutations Identified Previously
Confirmation of research findings
Result interpretation
Test development: Help
Test developed by laboratory but exempt from FDA oversight (eg. NYS CLEP approved, offered within a hospital or clinic)
Informed consent required: Help
Based on applicable state law
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 1
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 14
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 2
Method Category Help
Test method Help
Instrument *
Deletion/duplication analysis
Comparative Genomic Hybridization
Sequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
* Instrument: Not provided
Clinical Information
Test purpose: Help
Diagnosis; Mutation Confirmation; Risk Assessment
Target population: Help
This panel is designed for the detection of germline variants in 12 genes and 2 targeted variants known to be associated with an increased risk for developing venous thromboembolism.
Recommended fields not provided:
Technical Information
Test Comments: Help
A DEX Z-Code has been assigned for this panel, visit app.dexzcodes.com
Availability: Help
Tests performed
Entire test performed in-house

Test performance comments
Assay is performed at Versitit's Milwaukee clinical diagnostic lab location
Analytical Validity: Help
The analytical sensitivity of this test is >99% for single nucleotide changes and insertions and deletions of less than 20bp.
Assay limitations: Help
This assay does not detect large deletions or duplications (>20bp) or deletions, duplications or variants that are outside the regions sequenced.
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
Yes

Method used for proficiency testing: Help
Formal PT program

PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Not provided
NYS CLEP Approval: Help
Number: 68479
Status: Approved
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.